Skip to search.
 TSX Up 1.00% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
6.98 0.22(3.25%) Apr 16, 4:00PM EDT
Add to Portfolio
Prev Close:6.76
Open:6.89
Bid:6.12 x 300
Ask:8.60 x 200
1y Target Est:15.50
Beta:-0.030
Earnings Date:May 12 - May 16 (Est.)
Day's Range:6.78 - 7.15
52wk Range:5.83 - 12.89
Volume:98,112
Avg Vol (3m):218,202
Market Cap:301.31M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Must Read

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.58
Quarterly EPS Est (Mar-14) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback